ArticleTranslational cancer research2024

CTBP2 contributes to cisplatin resistance in lung adenocarcinoma by inhibiting generation of reactive oxygen species.

Mingqun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.